Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s diseaseWei‐Ming Su, Yong‐Ping Chen|Journal of Neurology Neurosurgery & Psychiatry|2023Cited by 150
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitroQing‐Qing Duan, Yong‐Ping Chen|BMC Medicine|2024Cited by 39